Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Cyxone AB | -783,159 | net | 20 Aug 2024 | tx 6+3,172,042−3,955,201 |
| Aptahem AB | 2,500 | net | 05 Dec 2018 | tx 1+2,500 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 20 Aug 2024 | PURCHASE | Cyxone AB | 3,125,000 | 0.04 SEK | first after silence |
| 02 Aug 2024 | SALE | Cyxone AB | 3,955,201 | 0.00 SEK | deriv |
| 13 Sept 2019 | PURCHASE | Cyxone AB | 9,154 | 5.89 SEK | |
| 10 Sept 2019 | PURCHASE | Cyxone AB | 9,077 | 5.94 SEK | |
| 29 Aug 2019 | PURCHASE | Cyxone AB | 8,811 | 6.81 SEK | |
| 05 Dec 2018 | PURCHASE | Aptahem AB | 2,500 | 4.00 SEK | |
| 12 Nov 2018 | PURCHASE | Cyxone AB | 20,000 | 2.50 SEK |
1 purchase reported after at least 12 months of silence — most recent on 20 Aug 2024.